ArticleMicroplastics (Basel, Switzerland)2026
Micro- and Nanoplastics and Pulmonary Health: The Current State of Research.
Article in Microplastics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Microplastics and Nanoplastics in the Human Diet: Sources of Exposure, Bioavailability, Toxicokinetics, and Systemic Health Effects.Molecules (Basel, Switzerland) · 2026Review
- Microplastics inhibit macrophage bioenergetics impairing homeostatic function and immune responsiveness.bioRxiv : the preprint server for biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Micro- and nanoplastics are human made environmental contaminants that pose a growing concern for our health, particularly through airborne exposures. Although human autopsy studies confirm that micro- and nanoplastics are retained in lung tissue, our understanding of their short- and long-term effects on the pulmonary system is limited. We reviewed the existing literature to evaluate the effects of micro- and nanoplastics on the respiratory system and how their downstream effects may induce respiratory disease. In vivo and in vitro studies demonstrate that micro- and nanoplastics appear to have the capacity to disrupt pulmonary homeostasis through oxidative stress, immune activation, epithelial remodeling, and surfactant interference. Unfortunately, most available micro- and nanoplastics exposure studies are conducted using environmentally irrelevant plastics at high doses, which limits the accuracy and validity of conclusions regarding biological mechanisms that may contribute to chronic lung disease. To close this gap, future studies must adopt standardized, human-relevant models and realistic exposure scenarios. This includes using advanced in vitro and ex vivo platforms, and environmentally representative micro- and nanoplastics (rather than polystyrene spheres) to improve clinical relevance and support effective prevention and risk mitigation strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.